bnc210
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Jun 30, 2016 (NCT02933606)
Timeline
Indications
Mechanism of action
CHRNA7 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bnc210
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06510504 | Phase 3 | Aug 6, 2024 | Bionomics Limited |
| NCT05193409 | Phase 2 | Feb 2, 2022 | Bionomics Limited |
| NCT04951076 | Phase 2 | Jul 27, 2021 | Bionomics Limited |
| NCT03548194 | Phase 2 | May 17, 2018 | Bionomics Limited |
| NCT02933606 | Phase 2 | Jun 30, 2016 | Bionomics Limited |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bionomics Limited | For profit | 5 | 5 | 2 | 2016 |
1 organizations
Page 1 / 1